Mangaonkar, Abhishek A. http://orcid.org/0000-0003-2458-9887
Lasho, Terra L.
Ketterling, Rhett P.
Reichard, Kaaren K.
Gangat, Naseema http://orcid.org/0000-0002-9104-6172
Al-Kali, Aref http://orcid.org/0000-0002-0824-3715
Begna, Kebede H.
Pardanani, Animesh
Al Ali, Najla H.
Talati, Chetasi http://orcid.org/0000-0002-2246-213X
Sallman, David http://orcid.org/0000-0003-0504-8233
Padron, Eric http://orcid.org/0000-0002-4707-7916
Patnaik, Mrinal M. http://orcid.org/0000-0001-6998-662X
Tefferi, Ayalew http://orcid.org/0000-0003-4605-3821
Komrokji, Rami http://orcid.org/0000-0002-1876-5269
Article History
Received: 17 October 2021
Revised: 16 January 2022
Accepted: 20 January 2022
First Online: 1 February 2022
Competing interests
: EP has received honoraria and/or serves on advisory boards of BluePrint, CTI, Stemline Therapeutics, Taiho, and BMS; and has received research funding from Kura, Incyte, and BMS. MP is on the advisory board of Stemline Therapeutics. All other authors declare no relevant conflicts of interest in relation to the manuscript.